Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures

by Kathy Jones on  February 7, 2014 at 9:07 PM Medical Gadgets
RSS Email Print This Page Comment bookmark
Font : A-A+

California-based Edwards Lifesciences Corporation revealed that it has received the CE Mark in Europe for the use of its valve-in-valve procedures using the SAPIEN XT transcatheter heart valve as a minimally invasive treatment option for patients who are at a high risk of surgery and who require a replacement of their surgical mitral or aortic valves.
 Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures
Edwards Lifesciences Receives CE Mark for SAPIEN XT System for Valve-In-Valve Procedures

The company revealed that SAPIEN XT valve can reside on top of a previously installed prosthetic valve and is the only device that has been approved for valve-in-valve procedures inside the mitral valve

"The European approval of the SAPIEN XT system for valve-in-valve procedures is a milestone achievement. While this is not a large financial opportunity, it represents an important benefit for patients unable to go through a second open-heart surgery to replace their failing bioprosthetic valves", the company's corporate vice president, transcatheter heart valves, Larry Woods said.



Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive